EARNINGS: MS International hails record profit; Dekel loss narrows
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Price | 0.325p on 30-06-2025 | at 18:50:07
---|---|
Change | -0.045p -12.16% |
Buy | 0.35p |
Sell | 0.30p |
Buy / Sell OBD Shares |
Last Trade: | Sell 300,000.00 at 0.3155p |
Day's Volume: | 26,131,126 |
Last Close: | 0.325p |
Open: | 0.375p |
ISIN: | GB00BD5H8572 |
Day's Range | 0.325p - 0.375p |
52wk Range: | 0.30p - 8.40p |
Market Capitalisation: | £6m |
VWAP: | 0.353529p |
Shares in Issue: | 1,958m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Oxford Biodyn (OBD) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 300,000 | 0.3155p | Ordinary |
16:24:41 - 30-Jun-25 |
Buy* | 764,000 | 0.355p | Suspected BUY Trade |
16:23:06 - 30-Jun-25 |
Unknown* | 4,000,000 | 0.325p | Ordinary |
16:22:13 - 30-Jun-25 |
Buy* | 5,714 | 0.35p | Ordinary |
16:17:11 - 30-Jun-25 |
Buy* | 150,000 | 0.3425p | Ordinary |
16:17:11 - 30-Jun-25 |
Sell* | 500,000 | 0.3155p | Ordinary |
16:16:53 - 30-Jun-25 |
Sell* | 500,000 | 0.35p | Ordinary |
16:00:31 - 30-Jun-25 |
Sell* | 500,000 | 0.35p | Ordinary |
16:00:21 - 30-Jun-25 |
Sell* | 500,000 | 0.35p | Ordinary |
16:00:13 - 30-Jun-25 |
Sell* | 154,062 | 0.357p | Ordinary |
15:33:06 - 30-Jun-25 |
Oxford Biodyn (OBD) Regulatory News |
||
Date | Source | Headline |
---|---|---|
30th Jun 2025 7:00 am | RNS | Interim Results |
27th Jun 2025 1:30 pm | RNS | Holding(s) in Company |
9th May 2025 7:00 am | RNS-R | OBD’s Oxford Lab accredited by UKAS |
10th Apr 2025 4:10 pm | RNS | Director/PDMR Shareholding |
2nd Apr 2025 7:00 am | RNS | PDMR Dealing |
28th Mar 2025 10:35 am | RNS | Result of AGM |
17th Mar 2025 7:00 am | RNS | Board Changes |
14th Mar 2025 5:25 pm | RNS | Holding(s) in Company |
13th Mar 2025 7:00 am | RNS-R | Expansion of OBD/Bupa UK insurance partnership |
5th Mar 2025 4:00 pm | RNS | Publication of 2024 Annual Report |